Apogee Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $31.21-$88.35 |
Market Cap | $6.4B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.22 |
News
See moreYahoo Finance • 19 days ago
Apogee Therapeutics prices upsized $350M offering at $70 a share
Yahoo Finance • 19 days ago
Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering
Yahoo Finance • 20 days ago
Stocks Sharply Higher as President Trump Seeks to End Iran War
Yahoo Finance • 21 days ago
How Apogee, Up 20%, Plans To Take On Rival Regeneron's Eczema Drug
About
CEO | Dr. Michael Thomas Henderson M.D. |
Address | Building 17, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 261 |